Shionogi & Co., Ltd. Competitors

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for Shionogi & Co., Ltd. and Abacus Health Products, as provided by MarketBeat.

Earnings and Valuation

This table compares Shionogi & Co., Ltd. and Abacus Health Products' revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Shionogi & Co., Ltd. and Abacus Health Products' net margins, return on equity and return on assets.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

Profitability

This table compares Shionogi & Co., Ltd. and Acreage's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for Shionogi & Co., Ltd. and Acreage, as provided by MarketBeat.

Acreage has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, analysts plainly believe Acreage is more favorable than Shionogi & Co., Ltd..

Earnings and Valuation

This table compares Shionogi & Co., Ltd. and Acreage's revenue, earnings per share (EPS) and valuation.

Summary

Acreage beats Shionogi & Co., Ltd. on 2 of the 2 factors compared between the two stocks.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Shionogi & Co., Ltd. and Applied Biosciences' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Shionogi & Co., Ltd. and Applied Biosciences, as provided by MarketBeat.com.

Valuation and Earnings

This table compares Shionogi & Co., Ltd. and Applied Biosciences' revenue, earnings per share and valuation.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Shionogi & Co., Ltd. and Ayr Strategies' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Shionogi & Co., Ltd. and Ayr Strategies, as provided by MarketBeat.com.

Ayr Strategies has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Shionogi & Co., Ltd..

Valuation and Earnings

This table compares Shionogi & Co., Ltd. and Ayr Strategies' revenue, earnings per share and valuation.

Summary

Ayr Strategies beats Shionogi & Co., Ltd. on 2 of the 2 factors compared between the two stocks.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) and Can B (NASDAQ:CANB) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Shionogi & Co., Ltd. and Can B's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Shionogi & Co., Ltd. and Can B, as provided by MarketBeat.com.

Valuation and Earnings

This table compares Shionogi & Co., Ltd. and Can B's revenue, earnings per share and valuation.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Shionogi & Co., Ltd. and Cansortium's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Shionogi & Co., Ltd. and Cansortium, as provided by MarketBeat.com.

Cansortium has a consensus price target of $1.20, indicating a potential upside of 39.67%. Given Cansortium's higher possible upside, analysts plainly believe Cansortium is more favorable than Shionogi & Co., Ltd..

Valuation and Earnings

This table compares Shionogi & Co., Ltd. and Cansortium's revenue, earnings per share and valuation.

Summary

Cansortium beats Shionogi & Co., Ltd. on 2 of the 2 factors compared between the two stocks.